Financials
Financial year 2025
MEDGENIX BENELUX from Wevelgem, company number BE0407171356, closed financial year 2025 with a result of € 1.9 million after tax. For that financial year MEDGENIX BENELUX recorded revenue of € 42.9 million and equity of € 17.5 million. Compared with financial year 2023, the result moved from € 2.6 million to € 1.9 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.
€ 17.5 million
▼ 37% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.9 million
▼ 26% vs 2023
Profit after tax over the fiscal year.
€ 14.7 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
122.3
▲ 1.8 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 9.2 million
▲ 6% vs 2023
€ 75,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 23,732
▼ 57% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 5.7 million
▲ 40% vs 2023
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 76 days on average.
€ 1.5 million
▼ 6% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 31,495,241 | € 35,920,245 | € 40,368,924 | € 42,899,280 | ▲ 6% |
| Profit after taxes | € 1,458,168 | € 833,944 | € 2,581,084 | € 1,898,905 | ▼ 26% |
| Equity | € 24,623,404 | € 25,457,348 | € 28,038,431 | € 17,542,010 | ▼ 37% |
| Total debts | € 6,220,873 | € 8,503,945 | € 8,025,472 | € 21,888,278 | ▲ 173% |
| Cash | - | - | € 14,614 | - | |
| Land & buildings | € 3,896,975 | € 4,639,698 | € 4,370,600 | € 5,698,290 | ▲ 30% |
| Retained profit | € 13,944,301 | € 14,778,245 | € 17,359,329 | € 6,862,907 | ▼ 60% |
| Dividend | € 0 | € 0 | € 0 | € 14,700,000 | |
| Balance sheet total | € 30,892,455 | € 33,984,337 | € 36,080,675 | € 39,430,288 | ▲ 9% |
| Employees (FTE) | 133.9 | 126.5 | 120.5 | 122.3 | ▲ 1.8 |
Key figures of MEDGENIX BENELUX, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDGENIX BENELUX?
What happened at MEDGENIX BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Geert Florizoone stepped down as director. NBB
- Magali Verbraeken stepped down as director. NBB
- Anja Van Winsberghe stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 1.9 million (▼ 26% vs 2023). Source: NBB ↗
- Geert Florizoone became a director. NBB
- Magali Verbraeken became a director. NBB
- Anja Van Winsberghe became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.5 million profit in 2021 to € 1.9 million profit in 2025.
Paid € 2.7 million in corporate taxes since 2021.
Best year ever: 2023, with € 2.6 million profit.
Paid out € 14.7 million in dividends to the owners in total.
Management
The shares are held by Perrigo Belgium NV (100%).
Directors
According to the 2025 annual accounts
Magali Verbraeken
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Belgium, Perrigo Capital, Perrigo Europe Invest, Oce-Bio, JAICO R.D.P., OMEGA PHARMA INTERNATIONAL, OMEGA PHARMA INNOVATION & DEVELOPMENT
since 2024 · until 2030
Anja Van Winsberghe
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Belgium, Perrigo Capital, Perrigo Holding, Perrigo Europe Invest, Oce-Bio, JAICO R.D.P., HRA PHARMA BENELUX +2 more
since 2020 · until 2026
Geert Florizoone
Director
since 2024 · until 2030
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vliegveld 21
8560 Wevelgem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
NEDZONE-AS, NL
Website info
Features
Security
Details
- Company number
- 0407.171.356
- VAT number
- BE 0407.171.356
- Registered office
- Vliegveld 21, 8560 Wevelgem
- Names & denominations
- MEDGENIX BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 21 June 1970
- Peppol
- Active · Active since 8 Dec 2025
- Contact
- medgenix.be
- Activities · NACE
Vervaardiging van geneesmiddelen
Vervaardiging van overige chemische producten
Vervaardiging van andere chemische producten, neg